ESR/ERS white paper on lung cancer screening

European Radiology

Volumn 25, Issue 9, 2015, Pages 2519-2531

  Kauczor, Hans Ulrich ^a,i   Bonomo, Lorenzo ^b   Gaga, Mina ^c   Nackaerts, Kristiaan ^d   Peled, Nir ^e   Prokop, Mathias ^f   Remy Jardin, Martine ^g   von Stackelberg, Oyunbileg ^a,i   Sculier, Jean Paul ^h  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c Athens Chest Hospital   (Greece)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e TEL AVIV UNIVERSITY   (Israel)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIV LILLE   (France)

^h JULES BORDET INSTITUTE   (Belgium)

ⁱ Member of the German Center for Lung Research   (Germany)

Author keywords

Low dose CT; Lung cancer screening; Overdiagnosis; Pulmonary nodule

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL CALCIFICATION; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC RADIOLOGIST; EUROPEAN; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MEDICAL SOCIETY; PRIORITY JOURNAL; PROGRAM COST EFFECTIVENESS; RADIATION DOSE; SMOKING CESSATION; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; EUROPE; LUNG TUMOR; PRACTICE GUIDELINE; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

EARLY DETECTION OF CANCER; EUROPE; HUMANS; LUNG NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938986584     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3697-0     Document Type: Article

References (83)

1. World Health Organization. Cancer. Fact Sheet Number 297. www.who.int/mediacentre/factsheets/fs297/en/ Last updated February 2015. Date last accessed: February 10, 2015.
2. Eurostat Press Office. 1 in 4 Deaths Caused by Cancer in the EU28. 2014; http://ec.europa.eu/eurostat/documents/2995521/6131615/3-25112014-BP-EN/aab2c2d3-aed9-430a-a561-e188b8ef49d8 Date last updated: November 25, 2014. Date last accessed: February 10, 2015.
3. Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714
4. Shi CL, Zhang XY, Han BH et al (2011) A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment. Med Oncol 28:1441–1446
5. Shlomi D, Ben-Avi R, Balmor GR et al (2014) Screening for lung cancer: time for large-scale screening by chest computed tomography. Eur Respir J 44:217–238
6. Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409
7. Pinsky PF, Church TR, Izmirlian G et al (2013) The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 119:3976–3983
8. Aberle DR, DeMello S, Berg CD et al (2013) Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369:920–931
9. van Iersel CA, de Koning HJ, Draisma G et al (2007) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120:868–874
10. Bach PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307:2418–2429
11. Saghir Z, Dirksen A, Ashraf H et al (2012) CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 67:296–301
12. Pastorino U, Rossi M, Rosato V et al (2012) Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21:308–315
13. Baldwin DR, Duffy SW, Wald NJ et al (2011) UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 66:308–313
14. Becker N, Motsch E, Gross ML et al (2012) Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 138:1475–1486
15. Wood DE, Eapen GA, Ettinger DS et al (2012) Lung cancer screening. J Natl Compr Canc Netw 10:240–265
16. Wood DE, Kazerooni E, Baum SL et al (2015) Lung cancer screening, version 1. J Natl Compr Canc Netw 13:23–34
17. Oken MM, Hocking WG, Kvale PA et al (2011) Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 306:1865–1873
18. Bach PB, Mirkin JN, Oliver TK, et al. The Role of CT Screening for Lung Cancer in Clinical Practice. The Evidence Based Practice Guideline of the American College of Chest Physicians and the American Society for Clinical Oncology. Alexandria, ACSO, 2012; Available from www.asco.org/institute-quality/role-ct-screening-lung-cancer-clinical-practice-evidence-based-practice-guideline
19. Jaklitsch MT, Jacobson FL, Austin JH et al (2012) The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 144:33–38
20. Wender R, Fontham ET, Barrera E Jr et al (2013) American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 63:107–117
21. Detterbeck FC, Mazzone PJ, Naidich DP et al (2013) Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e78S–e92S
22. Detterbeck FC, Lewis SZ, Diekemper R et al (2013) Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:7S–37S
23. US Preventive Services Task Force. Screening for Lung Cancer. Rockville, USPSTF Program Office, 2013. Available from www.uspreventiveservicestaskforce.org/uspstf13/lungcan/lungcanfact.pdf
24. Moyer VA (2014) Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160:330–338
25. US Department of Health and Human Services. Key Features of the Affordable Care Act. www.hhs.gov/healthcare/rights/ Date last updated: November 18, 2014. Date last accessed: February 10, 2015.
26. Centers for Medicare and Medicaid Services. Lung Cancer Screening with Low Dose Computed Tomography. www.cms.gov/medicare-coverage-database/details/medcac-meeting-details.aspx?MEDCACId=68 Date last accessed: February 10, 2015.
27. Centers for Medicare and Medicaid Services. Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439 N). Baltimore, Centers for Medicare and Medicaid Services, 2015. Available from www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274&bc=AAAAAAAAAgAAAA %3d %3d&
28. Simonato L, Agudo A, Ahrens W et al (2001) Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 91:876–887
29. Department US (1990) of Health and Human Services. From the Centers for Disease Control. Health benefits of smoking cessation. JAMA 264:1930
30. Marcus PM, Bergstralh EJ, Fagerstrom RM et al (2000) Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 92:1308–1316
31. Kubik AK, Parkin DM, Zatloukal P (2000) Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer 89:2363–2368
32. Church TR, Black WC, Aberle DR et al (2013) Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368:1980–1991
33. Infante M, Cavuto S, Lutman FR et al (2009) A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 180:445–453
34. Bach PB (2008) Overdiagnosis in lung cancer: different perspectives, definitions, implications. Thorax 63:298–300
35. McWilliams A, Tammemagi MC, Mayo JR et al (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369:910–919
36. Raji OY, Duffy SW, Agbaje OF et al (2012) Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med 157:242–250
37. Tammemagi MC, Katki HA, Hocking WG et al (2013) Selection criteria for lung-cancer screening. N Engl J Med 368:728–736
38. Kovalchik SA, Tammemagi M, Berg CD et al (2013) Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 369:245–254
39. de Koning HJ, Meza R, Plevritis SK et al (2014) Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 160:311–320
40. McCarthy WJ, Meza R, Jeon J et al (2012) Chapter 6: lung cancer in never smokers: epidemiology and risk prediction models. Risk Anal 32(suppl 1):S69–S84
41. Yano T, Haro A, Shikada Y et al (2011) Non-small cell lung cancer in never smokers as a representative ‘non-smoking-associated lung cancer’: epidemiology and clinical features. Int J Clin Oncol 16:287–293
42. Xu DM, Gietema H, de Koning H et al (2006) Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 54:177–184
43. van Klaveren RJ, Oudkerk M, Prokop M et al (2009) Management of lung nodules detected by volume CT scanning. N Engl J Med 361:2221–2229
44. McKee BJ, Regis SM, McKee AB et al (2015) Performance of ACR Lung-RADS in a Clinical CT Lung Screening Program. J Am Coll Radiol 12:273–276
45. Manos D, Seely JM, Taylor J et al (2014) The Lung Reporting and Data System (LU-RADS): a proposal for computed tomography screening. Can Assoc Radiol J 65:121–134
46. Field JK, Hansell DM, Duffy SW et al (2013) CT screening for lung cancer: countdown to implementation. Lancet Oncol 14:e591–e600
47. Xu DM, van der Zaag-Loonen HJ, Oudkerk M et al (2009) Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology 250:264–272
48. Ahn MI, Gleeson TG, Chan IH et al (2010) Perifissural nodules seen at CT screening for lung cancer. Radiology 254:949–956
49. van’t Westeinde SC, Horeweg N, Vernhout RM et al (2012) The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules. Chest 142:377–384
50. Prokop M (2014) Lung cancer screening: the radiologist’s perspective. Semin Respir Crit Care Med 35:91–98
51. Van’t Westeinde SC, Horeweg N, De Leyn P et al (2012) Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial. Eur J Cardiothorac Surg 42:420–429
52. Marshall HM, Bowman RV, Yang IA et al (2013) Screening for lung cancer with low-dose computed tomography: a review of current status. J Thorac Dis 5(suppl 5):S524–S539
53. Mulshine JL, D’Amico TA (2014) Issues with implementing a high-quality lung cancer screening program. CA Cancer J Clin 64:352–363
54. Aberle DR, Berg CD, Black WC et al (2011) The National Lung Screening Trial: overview and study design. Radiology 258:243–253
55. Cagnon CH, Cody DD, McNitt-Gray MF et al (2006) Description and implementation of a quality control program in an imaging-based clinical trial. Acad Radiol 13:1431–1441
56. Katsura M, Matsuda I, Akahane M et al (2013) Model-based iterative reconstruction technique for ultralow-dose chest CT: comparison of pulmonary nodule detectability with the adaptive statistical iterative reconstruction technique. Invest Radiol 48:206–212
57. National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII. Washington, The National Academies Press, 2006.
58. Pierce DA, Sharp GB, Mabuchi K (2003) Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors. Radiat Res 159:511–520
59. Furukawa K, Preston DL, Lonn S et al (2010) Radiation and smoking effects on lung cancer incidence among atomic bomb survivors. Radiat Res 174:72–82
60. Berrington de Gonzalez A, Kim KP, Berg CD (2008) Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen 15:153–158
61. Mettler FA Jr, Huda W, Yoshizumi TT et al (2008) Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 248:254–263
62. McCunney RJ, Li J (2014) Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors. Chest 145:618–624
63. Sox HC (2011) Better evidence about screening for lung cancer. N Engl J Med 365:455–457
64. Marshall D, Simpson KN, Earle CC et al (2001) Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer 32:227–236
65. Wisnivesky JP, Mushlin AI, Sicherman N et al (2003) The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest 124:614–621
66. Mahadevia PJ, Fleisher LA, Frick KD et al (2003) Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA 289:313–322
67. Manser R, Dalton A, Carter R et al (2005) Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 48:171–185
68. Black WC, Gareen IF, Soneji SS et al (2014) Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 371:1793–1802
69. Folland SGA, Stano M (2010) Economic Effiencey and Cost-Benefit Analysis. The Economics of Health and Health Care. Prentice Hall, Boston
70. Horeweg N, van der Aalst CM, Thunnissen E et al (2013) Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 187:848–854
71. Devaraj A (2015) Missed cancers in lung cancer screening—more than meets the eye. Eur Radiol 25:89–91
72. Vestbo J, Hurd SS, Agusti AG et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–365
73. Masala S, Magrini A, Taglieri A et al (2014) Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP). Eur Radiol 24:1577–1585
74. Hansell DM, Bankier AA, MacMahon H et al (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722
75. Washko GR, Lynch DA, Matsuoka S et al (2010) Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 17:48–53
76. Castaldi PJ (2013) San Jose Estepar R, et al. Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers. Am J Respir Crit Care Med 188:1083–1090
77. Estepar RS, Kinney GL, Black-Shinn JL et al (2013) Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med 188:231–239
78. Shemesh J, Henschke CI, Shaham D et al (2010) Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology 257:541–548
79. Budoff MJ, Nasir K, Kinney GL et al (2011) Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort. J Cardiovasc Comput Tomogr 5:113–118
80. Mets OM, Vliegenthart R, Gondrie MJ et al (2013) Lung cancer screening CT-based prediction of cardiovascular events. JACC Cardiovasc Imaging 6:899–907
81. Pecot CV, Li M, Zhang XJ et al (2012) Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev 21:786–792
82. Daly S, Rinewalt D, Fhied C et al (2013) Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J Thorac Oncol 8:31–36
83. Jett JR, Peek LJ, Fredericks L et al (2014) Audit of the autoantibody test, EarlyCDT(R)-lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Lung Cancer 83:51–55